125 related articles for article (PubMed ID: 20206982)
1. Defining detection threshold and improving analytical proficiency of HPV testing in clinical specimens.
Chao FY; Chao A; Huang CC; Hsueh S; Yang JE; Huang HJ; Wang LC; Lin CT; Chou HH; Lai CH
Gynecol Oncol; 2010 May; 117(2):302-7. PubMed ID: 20206982
[TBL] [Abstract][Full Text] [Related]
2. Viral load of high-risk human papillomaviruses as reliable clinical predictor for the presence of cervical lesions.
Schmitt M; Depuydt C; Benoy I; Bogers J; Antoine J; Pawlita M; Arbyn M;
Cancer Epidemiol Biomarkers Prev; 2013 Mar; 22(3):406-14. PubMed ID: 23334590
[TBL] [Abstract][Full Text] [Related]
3. Detection of HPV in Norwegian cervical biopsy specimens with type-specific PCR and reverse line blot assays.
Roberts CC; Tadesse AS; Sands J; Halvorsen T; Schofield TL; Dalen A; Skjeldestad FE; Jansen KU
J Clin Virol; 2006 Aug; 36(4):277-82. PubMed ID: 16765639
[TBL] [Abstract][Full Text] [Related]
4. Changes in DNA Level of Oncogenic Human Papillomaviruses Other Than Types 16 and 18 in Relation to Risk of Cervical Intraepithelial Neoplasia Grades 2 and 3.
Xi LF; Schiffman M; Hughes JP; Galloway DA; Koutsky LA; Kiviat NB
Cancer Epidemiol Biomarkers Prev; 2019 Aug; 28(8):1388-1394. PubMed ID: 31101617
[TBL] [Abstract][Full Text] [Related]
5. PCR detection rates of high risk human papillomavirus DNA in paired self-collected urine and cervical scrapes after laser CO2 conization for high-grade cervical intraepithelial neoplasia.
Fambrini M; Penna C; Pieralli A; Bussani C; Fallani MG; Andersson KL; Scarselli G; Marchionni M
Gynecol Oncol; 2008 Apr; 109(1):59-64. PubMed ID: 18255129
[TBL] [Abstract][Full Text] [Related]
6. Comparison between the Hybrid Capture II test and a PCR-based human papillomavirus detection method for diagnosis and posttreatment follow-up of cervical intraepithelial neoplasia.
Söderlund-Strand A; Rymark P; Andersson P; Dillner J; Dillner L
J Clin Microbiol; 2005 Jul; 43(7):3260-6. PubMed ID: 16000445
[TBL] [Abstract][Full Text] [Related]
7. High-risk human papillomavirus genotype distribution and attribution to cervical cancer and precancerous lesions in a rural Chinese population.
Zhao XL; Hu SY; Zhang Q; Dong L; Feng RM; Han R; Zhao FH
J Gynecol Oncol; 2017 Jul; 28(4):e30. PubMed ID: 28541628
[TBL] [Abstract][Full Text] [Related]
8. [Evaluation of CIN2+ /CIN3+ risk of different HPV subtypes infection combined with abnormal cytology status].
Luo HX; Du H; Liu ZH; Zhang LJ; Wang C; Wu RF
Zhonghua Zhong Liu Za Zhi; 2018 Mar; 40(3):232-238. PubMed ID: 29575846
[No Abstract] [Full Text] [Related]
9. Correlation between multi-type human papillomavirus infections and viral loads and the cervical pathological grade.
Li Y; Wang H; Zhang Y; Jing X; Wu N; Hou Y; Hao C
Int J Gynaecol Obstet; 2021 Jan; 152(1):96-102. PubMed ID: 33020921
[TBL] [Abstract][Full Text] [Related]
10. [Clinical study on cervical intraepithelial neoplasia with high-risk HPV infection among pregnant women].
He Y; Wu YM; Wang T; Song F; Wang Y; Zhao Q; Kong WM; Duan W; Zhu L; Zhang WY
Zhonghua Fu Chan Ke Za Zhi; 2012 Aug; 47(8):598-602. PubMed ID: 23141180
[TBL] [Abstract][Full Text] [Related]
11. The clinical performance of primary HPV screening, primary HPV screening plus cytology cotesting, and cytology alone at a tertiary care hospital.
Choi JW; Kim Y; Lee JH; Kim YS
Cancer Cytopathol; 2016 Feb; 124(2):144-52. PubMed ID: 26457676
[TBL] [Abstract][Full Text] [Related]
12. Clinical performance of Anyplex II HPV28 by human papillomavirus type and viral load in a referral population.
Baasland I; Romundstad PR; Eide ML; Jonassen CM
PLoS One; 2019; 14(1):e0210997. PubMed ID: 30673759
[TBL] [Abstract][Full Text] [Related]
13. Combining HPV DNA load with p16/Ki-67 staining to detect cervical precancerous lesions and predict the progression of CIN1-2 lesions.
Li Y; Liu J; Gong L; Sun X; Long W
Virol J; 2019 Oct; 16(1):117. PubMed ID: 31619262
[TBL] [Abstract][Full Text] [Related]
14. Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHENA study.
Castle PE; Stoler MH; Wright TC; Sharma A; Wright TL; Behrens CM
Lancet Oncol; 2011 Sep; 12(9):880-90. PubMed ID: 21865084
[TBL] [Abstract][Full Text] [Related]
15. Human papillomavirus (HPV) detection using in situ hybridization in histologic samples: correlations with cytologic changes and polymerase chain reaction HPV detection.
Kelesidis T; Aish L; Steller MA; Aish IS; Shen J; Foukas P; Panayiotides J; Petrikkos G; Karakitsos P; Tsiodras S
Am J Clin Pathol; 2011 Jul; 136(1):119-27. PubMed ID: 21685039
[TBL] [Abstract][Full Text] [Related]
16. Clinical validation of the PCR-reverse dot blot human papillomavirus genotyping test in cervical lesions from Chinese women in the Fujian province: a hospital-based population study.
Sun P; Song Y; Ruan G; Mao X; Kang Y; Dong B; Lin F
J Gynecol Oncol; 2017 Sep; 28(5):e50. PubMed ID: 28657218
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of human papillomavirus testing in primary screening for cervical abnormalities: comparison of sensitivity, specificity, and frequency of referral.
Kulasingam SL; Hughes JP; Kiviat NB; Mao C; Weiss NS; Kuypers JM; Koutsky LA
JAMA; 2002 Oct; 288(14):1749-57. PubMed ID: 12365959
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the clinical performances of the AdvanSure HPV Screening Real-Time PCR, the Abbott Real-Time High-Risk HPV Test, and the Hybrid Capture High-Risk HPV DNA Test for Cervical Cancer Screening.
Chung HS; Hahm C; Lee M
J Virol Methods; 2014 Sep; 205():57-60. PubMed ID: 24814874
[TBL] [Abstract][Full Text] [Related]
19. DNA- versus RNA-based methods for human papillomavirus detection in cervical neoplasia.
Lie AK; Risberg B; Borge B; Sandstad B; Delabie J; Rimala R; Onsrud M; Thoresen S
Gynecol Oncol; 2005 Jun; 97(3):908-15. PubMed ID: 15943992
[TBL] [Abstract][Full Text] [Related]
20. Detection and genotyping of HPV-DNA through different types of diagnostic platforms in liquid-based cervical-cytology samples.
Cassani B; Soldano G; Finocchiaro D; Conti S; Bulfamante A; Lemorini G; Bulfamante G
Pathologica; 2018 Dec; 110(4):294-301. PubMed ID: 30799441
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
